BridgeMD
New treatment option for Diabetes Mellitus Type 2 in Obese
Official title Normalized Glucose Levels in Type 2 Diabetes With Carbohydrate or Caloric Restriction
ClinicalTrials.gov ID: NCT05801614
What this study is testing
- What it's testing
- This is a randomized controlled trial to determine whether a low-carbohydrate (LC) diet can lead to normalized blood glucose levels in patients with short duration of type 2 diabetes (T2D). Previous studies have shown that caloric restricted diet leading to weight loss can normalize blood glucose levels in approximately 50% of patients with a short duration of diabetes type 2.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 24 to 70
You may be able to join if
- HbA1c \> 48 mmol/mol (with or without medical treatment);
- less than 6 years since the diagnosis of T2D
- BMI ≥ 27 kg/m2 (≥ 25 kg/m2 for Asians).
You likely can't join if
- Insulin deficiency.
- HbA1c concentration of 12% or more (≥108 mmol/mol),
- treatment with sulphonyl urea or sodium-glucose-cotrasporter2-inhibitor (SGL2-i),
- myocardial infarction within the previous 6 months,
- severe or unstable heart failure
- other severe diseases including cancer, psychiatric/eating disorders, severe depression - substance abuse,
See the full eligibility criteria
- HbA1c \> 48 mmol/mol (with or without medical treatment);
- less than 6 years since the diagnosis of T2D
- BMI ≥ 27 kg/m2 (≥ 25 kg/m2 for Asians).
- Insulin deficiency.
- HbA1c concentration of 12% or more (≥108 mmol/mol),
- treatment with sulphonyl urea or sodium-glucose-cotrasporter2-inhibitor (SGL2-i),
- myocardial infarction within the previous 6 months,
- severe or unstable heart failure
- other severe diseases including cancer, psychiatric/eating disorders, severe depression - substance abuse,
- conditions that may affect the ability of patients to participate in the study
The study team makes the final eligibility decision.
Where it's taking place
- Stockholm, Sweden
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 24 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Stockholm, Sweden. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.